Akero Therapeutics Target Price

See how AKRO's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$54.65

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2025-10-10	H.C. Wainwright	$54	1.2% downside
2025-10-09	Jefferies	$56	2.5% upside
2025-10-09	Canaccord Genuity	$54	1.2% downside
2025-09-04	H.C. WainwrightAndrew Fein	$72	31.7% upside
2024-09-17	H.C. WainwrightEd Arce	$50	8.5% downside
2024-06-12	Canaccord GenuityEdward Nash	$56	2.5% upside
2024-06-10	Wolfe ResearchAndy Chen	$40	26.8% downside
2024-05-15	Evercore ISILiisa Bayko	$38	30.5% downside
2023-10-11	H.C. WainwrightEd Arce	$40	26.8% downside
2022-09-13	Evercore ISILiisa Bayko	$50	8.5% downside

Akero Therapeutics (AKRO) FAQ

Stockcircle tracks target price for Akero Therapeutics (AKRO), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Akero Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main AKRO overview so you can move from this figure to the surrounding analysis quickly.